For full functionality of this site it is necessary to enable JavaScript
Market & News
Stocks
Indices
Debt Securities
ETFs
ETPs
Retail Bonds
Covered Warrants
Structured Products
RNS Search
Home
›
Stocks
›
AZN
›
News
1 / 10
Next
Regulatory
06 Feb 07:00 -
US FDA grants Fasenra Orphan Drug Designation
05 Feb 07:05 -
US FDA grants Breakthrough Therapy Designation
05 Feb 07:00 -
EMA grants PRIME eligibility for MEDI8897
01 Feb 15:00 -
Total Voting Rights
01 Feb 13:17 -
Forxiga receives positive EU CHMP opinion
25 Jan 14:00 -
Completion of divestment of US Synagis rights
07 Jan 13:00 -
AstraZeneca announces organisational changes
02 Jan 15:00 -
Total Voting Rights
20 Dec 13:47 -
Bevespi Aerosphere approved in the EU for COPD
20 Dec 07:05 -
Lynparza meets primary endpoint in SOLO-3 trial
20 Dec 07:00 -
Phase III ROCKIES and OLYMPUS roxadustat trials
19 Dec 18:31 -
FDA approves Lynparza as 1L maintenance therapy
18 Dec 09:09 -
Roxadustat approved in China for the treatment of
14 Dec 07:00 -
Directorate Change
07 Dec 07:00 -
Update on the Phase III EAGLE trial of Imfinzi
06 Dec 07:00 -
Divestment of rights to Covis completed
04 Dec 15:00 -
Director/PDMR Shareholding
03 Dec 16:00 -
Total Voting Rights
03 Dec 16:00 -
Block listing Interim Review
03 Dec 07:00 -
Grünenthal Agreement for Nexium, Vimovo Completed
Stocks
·
Indices
·
Debt Securities
·
ETFs
·
ETPs
·
Retail Bonds
Covered Warrants
·
Structured Products
·
Funds